GlaxoSmithKline and Baxter Feature in Line up at Smithers Rapra Extractables and Leachables European Conference 2013

  GlaxoSmithKline and Baxter Feature in Line up at Smithers Rapra Extractables
  and Leachables European Conference 2013

  7^th Extractables and Leachables conference to be held in London, UK from
                             10-11 December 2013

Business Wire

LEATHERHEAD, England -- September 25, 2013

The Extractables and Leachables (E&L Europe) conference full agenda for 2013
has been revealed. The conference will feature a two day speaker programme
covering analytical advances in E&Ls and best practises from the materials,
toxicologist and pharmaceutical company perspectives, plus poster sessions and
extended networking opportunities.

Last year’s E&L Europe saw a record attendance of delegates: pharmaceutical
manufacturers, medical device manufacturers, packaging and materials suppliers
to CROs, government and academia. London’s event is already on track to
deliver an even greater attended conference.

E&L Europe 2013 will cover the latest developments from industry practitioners
and working groups to meet regulatory requirements and ensure compatibility in
drug-package combinations. Speakers include: Dr Mike Hodgson from
GlaxoSmithKline, Thilde Marboe from Ferring Pharmaceuticals, Dr Reinhard Stidl
from Baxter Innovations and more.

Dr James Stern of Borealis will provide a unique perspective on how a polymer
producer can support the Healthcare industry, he sees great value in the E&L
events and comments “The industry needs to understand what is possible and
what is not possible and that can only be done if we have this type of forum
to discuss the challenges and opportunities. We are all experts in our areas
and by sharing that information realistic expectation levels can be achieved.”

This is a key aim of Smithers Rapra’s conferences, bringing together various
stakeholders regarding how to address the key issues related to E&Ls for all
drug product types and medical devices, in order to ensure safety in the
industry. Helping to foster this communication, Dr Dennis Jenke from Baxter
Healthcare, will deliver an exclusive update to all attendees, following his
attendance at the USP forum, on the evolving USP standards for the
characterisation and chemical safety assessment of plastics used in
pharmaceutical applications.

Further highlights include case studies from Waters Corporation, Gerresheimer
and the BioPhorum Operations Group on SUS components, elemental impurities and
COP materials. New for 2013 is the poster session, allowing attendees to hear
more about recent research and findings relating to all areas of E&Ls.

For more information on E&L Europe 2013 visit

View more information on Smithers Rapra


Smithers Rapra
Jo Martin
+44 (0)1372 802000
Press spacebar to pause and continue. Press esc to stop.